248 related articles for article (PubMed ID: 30612545)
1. Total hysterectomy versus uterine evacuation for preventing post-molar gestational trophoblastic neoplasia in patients who are at least 40 years old: a systematic review and meta-analysis.
Zhao P; Lu Y; Huang W; Tong B; Lu W
BMC Cancer; 2019 Jan; 19(1):13. PubMed ID: 30612545
[TBL] [Abstract][Full Text] [Related]
2. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
[TBL] [Abstract][Full Text] [Related]
3. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
4. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
[TBL] [Abstract][Full Text] [Related]
6. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
8. Total laparoscopic hysterectomy in combination with dilation and evacuation of an 18-week-sized uterus with gestational trophoblastic neoplasia: a novel treatment approach.
Patel M; Stuparich M; Nahas S
Am J Obstet Gynecol; 2021 Mar; 224(3):314-315. PubMed ID: 33197418
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study.
Zhao P; Chen Q; Lu W
BMC Cancer; 2017 Nov; 17(1):733. PubMed ID: 29121880
[TBL] [Abstract][Full Text] [Related]
11. Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhao P; Yu Y; Du M; Xu J; Lu W
Int J Gynaecol Obstet; 2024 Apr; 165(1):34-42. PubMed ID: 37753799
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
[TBL] [Abstract][Full Text] [Related]
13. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
[TBL] [Abstract][Full Text] [Related]
14. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
[TBL] [Abstract][Full Text] [Related]
15. Surgery including fertility-sparing treatment of GTD.
Ngu SF; Ngan HYS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
[TBL] [Abstract][Full Text] [Related]
16. Management of gestational trophoblastic disease in developing countries.
Sivanesaratnam V
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):925-42. PubMed ID: 14614890
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
[TBL] [Abstract][Full Text] [Related]
18. Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.
Sun SY; Melamed A; Joseph NT; Gockley AA; Goldstein DP; Bernstein MR; Horowitz NS; Berkowitz RS
Int J Gynecol Cancer; 2016 Feb; 26(2):367-70. PubMed ID: 26588240
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features of Gestational Trophoblastic Disease in Aged Women in South Vietnam.
Nguyen BQ; Vo TM; Phan VTT; Nguyen C; Vu H; Vo B
Yonsei Med J; 2023 Apr; 64(4):284-290. PubMed ID: 36996900
[TBL] [Abstract][Full Text] [Related]
20. Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience.
Giorgione V; Bergamini A; Cioffi R; Pella F; Rabaiotti E; Petrone M; Candiani M; Mangili G
Int J Gynecol Cancer; 2017 Mar; 27(3):550-553. PubMed ID: 28129241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
